EX-99.1 2 v191932_ex99-1.htm Unassociated Document
 
press information

MOOG INC., EAST AURORA, NEW YORK 14052   TEL-716/652-2000   FAX -716/687-4457

 
Immediate
 
contact
 
Ann Marie Luhr
   
July 30, 2010
     
716-687-4225
 
 
 
MOOG’S THIRD QUARTER EPS INCREASES 73%

Moog Inc. (NYSE: MOG.A and MOG.B) announced today third quarter earnings of $29.2 million, or $.64 a share, an increase of 73% over last year’s $.37 per share.  Sales in the quarter of $537 million were up 21% from last year’s $445 million.

Aircraft sales in the quarter of $191 million were up 18%, or $30 million, from a year ago.  Of the increase, $25 million came from the recent acquisition of the GE Actuation business in the U.K.  Military aircraft sales at $116 million were up 12%, or $13 million.  Almost all of that increase came from the acquisition.  Sales on the F-35 program were down by $3 million, the net impact of the development program winding down and the ramp-up of production.  Revenues were up on the V-22 tilt rotor, the Blackhawk helicopter, and in the military aftermarket.

Commercial Aircraft sales of $66 million were up $19 million, or 39%.  The acquisition provided most of that increase.  Sales were up at Boeing and Airbus.  Sales on business jets were even with last year.  Commercial aftermarket revenue, at $20 million, was down slightly in the quarter.  Our new navigation aids product line had sales of $9.3 million, down 14% from last year.  The reduction had to do with delays in the award of certain military programs.

Space and Defense sales of $87 million were up 35% in the quarter.  Sales were up on controls for satellites, on launch vehicles and tactical missiles.  Sales in defense controls surged because of a large order for Driver’s Vision Enhancer systems.  Revenue in security and surveillance and naval applications was about the same as last year.

The Industrial segment is recovering from the global industrial recession.  Revenue was up 26% to $129 million.  Sales in the wind energy business of $29 million were up 54% from last year due to the LTi REEnergy acquisition.  Sales in the capital equipment market of $43 million were up 38% on increases in sales of controls for plastics making machinery, metal forming equipment and specialized test equipment.  Sales of motion bases for flight training simulators were at the same level as last year and sales of controls for conventional power generation was the only category that did not see sales growth.
 


The Components segment had sales in the quarter of $96 million, up 6% from a year ago.  The growth occurred in the aircraft and industrial products.  The Company had very strong sales in the quarter of fiber optic controls used on the Eurofighter aircraft and broad-based strength in components for commercial avionics.  Industrial sales growth came in slip rings for wind turbines and in a general improvement in the automation market.  Component sales in space and defense held even in the quarter.  Sales of marine products were down from the very high levels of last year’s third quarter, but improved from the most recent quarter.

The Company’s Medical Devices segment had much improved sales at $33 million, up 29% from a year ago.  The sales increase was across the board in pumps, administration sets and sensors and handpieces.

The current backlog of $1.148 billion was up 16% from the same quarter a year ago.

The Company confirmed its earnings guidance for the year ending September 2010.  Sales are now forecast at $2.089 billion, with net earnings of $107 million and earnings per share of $2.35.

The Company also provided its initial projection for fiscal 2011.  Sales are forecasted to increase by 7% to $2.235 billion with net earnings of $124 million, and earnings per share of $2.70, a 15% increase.

 “Our recession is over,” said R.T. Brady, Chairman and CEO.  “Sales are strong and continue to grow.  Our major aircraft development programs are moving into production.  Space and Defense and the Components Group are having a very strong year.  Sales are improving in both Industrial and Medical.  We’re optimistic that 2011 will put us back on our growth trajectory.”

Moog Inc. is a worldwide designer, manufacturer, and integrator of precision control components and systems.  Moog’s high-performance systems control military and commercial aircraft, satellites and space vehicles, launch vehicles, missiles, automated industrial machinery, wind energy, marine and medical equipment.  Additional information about the Company can be found at www.moog.com.


Cautionary Statement


Information included or incorporated by reference herein that does not consist of historical facts, including statements accompanied by or containing words such as “may,” “will,” “should,” “believes,” “expects,” “expected,” “intends,” “plans,” “projects,” “approximate,” “estimates,” “predicts,” “potential,” “outlook,” “forecast,” “anticipates,” “presume” and “assume,” are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future performance and are subject to several factors, risks and uncertainties, the impact or occurrence of which could cause actual results to differ materially from the results described in the forward-looking statements. These important factors, risks and uncertainties include:
 

 
i.    
fluctuations in general business cycles for commercial aircraft, military aircraft, space and defense products, industrial capital goods and medical devices;
ii.    
our dependence on government contracts that may not be fully funded or may be terminated;
iii.    
our dependence on certain major customers, such as The Boeing Company and Lockheed Martin, for a significant percentage of our sales;
iv.    
delays by our customers in the timing of introducing new products, which may affect our earnings and cash flow;
v.    
the possibility that the demand for our products may be reduced if we are unable to adapt to technological change;
vi.    
intense competition, which may require us to lower prices or offer more favorable terms of sale;
vii.    
our indebtedness, which could limit our operational and financial flexibility;
viii.    
the possibility that new product and research and development efforts may not be successful, which could reduce our sales and profits;
ix.    
increased cash funding requirements for pension plans, which could occur in future years based on assumptions used for our defined benefit pension plans, including returns on plan assets and discount rates;
x.    
a write-off of all or part of our goodwill or intangible assets, which could adversely affect our operating results and net worth and cause us to violate covenants in our bank agreements;
xi.    
the potential for substantial fines and penalties or suspension or debarment from future contracts in the event we do not comply with regulations relating to defense industry contracting;
xii.    
the potential for cost overruns on development jobs and fixed-price contracts and the risk that actual results may differ from estimates used in contract accounting;
xiii.    
the possibility that our subcontractors may fail to perform their contractual obligations, which may adversely affect our contract performance and our ability to obtain future business;
xiv.    
our ability to successfully identify and consummate acquisitions, and integrate the acquired businesses and the risks associated with acquisitions, including that the acquired businesses do not perform in accordance with our expectations, and that we assume unknown liabilities in connection with acquired businesses for which we are not indemnified;
xv.    
our dependence on our management team and key personnel;
xvi.    
the possibility of a catastrophic loss of one or more of our manufacturing facilities;
xvii.    
the possibility that future terror attacks, war or other civil disturbances could negatively impact our business;
xviii.    
that our operations in foreign countries could expose us to political risks and adverse changes in local, legal, tax and regulatory schemes;
xix.    
the possibility that government regulation could limit our ability to sell our products outside the United States;
xx.    
product quality or patient safety issues with respect to our medical devices business that could lead to product recalls, withdrawal from certain markets, delays in the introduction of new products, sanctions, litigation, declining sales or actions of regulatory bodies and government authorities;
xxi.    
the impact of product liability claims related to our products used in applications where failure can result in significant property damage, injury or death and in damage to our reputation;
xxii.    
changes in medical reimbursement rates of insurers to medical service providers, which could affect sales of our medical products;
xxiii.    
the possibility that litigation results may be unfavorable to us;
 

 
xxiv.    
our ability to adequately enforce our intellectual property rights and the possibility that third parties will assert intellectual property rights that prevent or restrict our ability to manufacture, sell, distribute or use our products or technology;
xxv.    
foreign currency fluctuations in those countries in which we do business and other risks associated with international operations;
xxvi.    
the cost of compliance with environmental laws;
xxvii.    
the risk of losses resulting from maintaining significant amounts of cash and cash equivalents at financial institutions that are in excess of amounts insured by governments;
xxviii.    
the inability to modify, to refinance or to utilize amounts presently available to us under our credit facilities given uncertainties in the credit markets;
xxix.    
our ability to meet the restrictive covenants under our credit facilities since a breach of any of these covenants could result in a default under our credit agreements; and
xxx.    
our customers’ inability to continue operations or to pay us due to adverse economic conditions or their inability to access available credit.

 
 
 

 

CONSOLIDATED STATEMENTS OF EARNINGS
(dollars in thousands, except per share data)

   
 
Three Months Ended
   
Nine Months Ended
 
   
 
July 3,
   
June 27,
   
July 3,
   
June 27,
 
   
 
2010
   
2009
   
2010
   
2009
 
                                 
Net sales
  $ 536,775     $ 445,160     $ 1,542,441     $ 1,344,583  
Cost of sales
    380,828       319,410       1,094,191       945,213  
Gross profit
    155,947       125,750       448,250       399,370  
   
                               
Research and development
    25,780       22,805       75,166       72,127  
Selling, general and administrative
    79,296       70,545       233,521       208,550  
Restructuring expense
    1,653       9,946       4,792       9,946  
Interest
    9,387       9,471       29,363       28,494  
Equity in earnings of LTi and other
    (163 )     (3,409 )     467       (9,014 )
Earnings before income taxes
    39,994       16,392       104,941       89,267  
Income taxes
    10,762       496       29,147       19,409  
Net earnings
  $ 29,232     $ 15,896     $ 75,794     $ 69,858  
   
                               
Net earnings per share
                               
   Basic
  $ 0.64     $ 0.37     $ 1.67     $ 1.64  
   Diluted
  $ 0.64     $ 0.37     $ 1.66     $ 1.63  
   
                               
Average common shares outstanding
                               
   Basic
    45,371,995       42,571,843       45,356,752       42,571,608  
   Diluted
    45,753,917       42,837,237       45,692,348       42,882,372  

 
 

 

Moog Inc.
CONSOLIDATED SALES AND OPERATING PROFIT
(dollars in thousands)

   
 
Three Months Ended
   
Nine Months Ended
 
   
 
July 3,
   
June 27,
   
July 3,
   
June 27,
 
   
2010
   
2009
   
2010
   
2009
 
Net Sales
                       
   Aircraft Controls
  $ 191,172     $ 161,553     $ 554,985     $ 486,726  
   Space and Defense Controls
    87,466       64,753       236,041       204,455  
   Industrial Systems
    128,998       102,452       385,791       316,999  
   Components
    95,684       90,413       270,429       256,421  
   Medical Devices
    33,455       25,989       95,195       79,982  
Net sales
  $ 536,775     $ 445,160     $ 1,542,441     $ 1,344,583  
Operating Profit (Loss) and Margins
                               
   Aircraft Controls
  $ 17,262     $ 12,988     $ 54,447     $ 41,007  
   
    9.0 %     8.0 %     9.8 %     8.4 %
   Space and Defense Controls
    8,367       7,110       24,564       30,496  
   
    9.6 %     11.0 %     10.4 %     14.9 %
   Industrial Systems
    12,244       812       31,564       23,171  
   
    9.5 %     0.8 %     8.2 %     7.3 %
   Components
    18,315       14,689       44,833       44,739  
   
    19.1 %     16.2 %     16.6 %     17.4 %
   Medical Devices
    (683 )     (4,360 )     (532 )     (6,661 )
   
    (2.0 )%     (16.8 )%     (0.6 )%    
(8.3
)%
Total operating profit
    55,505       31,239       154,876       132,752  
   
    10.3 %     7.0 %     10.0 %     9.9 %
   
                               
Deductions from Operating Profit
                               
   Interest expense
    9,387       9,471       29,363       28,494  
   Equity-based compensation expense
    991       1,031       4,669       4,651  
   Corporate expenses and other
    5,133       4,345       15,903       10,340  
Earnings before Income Taxes
  $ 39,994     $ 16,392     $ 104,941     $ 89,267  

 
 

 

Moog Inc.
CONSOLIDATED BALANCE SHEETS
(dollars in thousands)

       
 
July 3,
   
October 3,
 
       
 
2010
   
2009
 
Cash    
  $ 91,116     $ 81,493  
Receivables  
    575,982       547,571  
Inventories  
    474,714       484,261  
Other current assets  
    98,642       97,073  
Total current assets  
    1,240,454       1,210,398  
Property, plant and equipment  
    474,220       481,726  
Goodwill and intangible assets  
    904,913       918,770  
Other non-current assets  
    20,818       23,423  
Total assets  
  $ 2,640,405     $ 2,634,317  
       
               
Notes payable  
  $ 3,333     $ 16,971  
Current installments of long-term debt  
    1,745       1,541  
Contract loss reserves  
    37,899       50,190  
Other current liabilities  
    411,876       377,559  
Total current liabilities  
    454,853       446,261  
Long-term debt  
    777,198       814,574  
Other long-term liabilities  
    291,000       308,449  
Total liabilities  
    1,523,051       1,569,284  
Shareholders' equity  
    1,117,354       1,065,033  
Total liabilities and shareholders' equity  
  $ 2,640,405     $ 2,634,317